ArticleJAMA network open2022

Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019.

S M Qasim Hussaini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.